PNT2258

· Sierra Oncology LLC - a GSK company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PNT2258, covering 2020-03-10 to 2020-04-22. Get the full timeline:

Most recent: Clinical Trial Update: PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) [Phase 2]